GC-Rich Sequence DNA-Binding Factor 2 (GCFC2) (Middle Region) Peptid
GCFC2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle GCFC2 Produkte
- GCFC2 (GC-Rich Sequence DNA-Binding Factor 2 (GCFC2))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- QKQKKVFEEV QDDFCNIQNI LLKFQQWREK FPDSYYEAFI SLCIPKLLNP
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- TCF9 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- GCFC2 (GC-Rich Sequence DNA-Binding Factor 2 (GCFC2))
- Hintergrund
-
The first mRNA transcript isolated for this gene was part of an artificial chimera derived from two distinct gene transcripts and a primer used in the cloning process (see Genbank accession M29204). A positively charged amino terminus present only in the chimera was determined to bind GC-rich DNA, thus mistakenly thought to identify a transcription factor gene.
Alias Symbols: GCF, TCF9, DNABF, C2orf3
Protein Size: 781 - Gen-ID
- 6936
- NCBI Accession
- NM_001201334, NP_003194
- UniProt
- P16383
-
Sie sind hier:
